CD27 and acute myeloid leukemia: These results are supported by other studies which display a block in NK cell maturation in animal experimental models of AML, evidenced by their incapacity to pass from stage 2 (CD27+CD11b−) to stage 3 (CD27+CD11b+) NK cells in the spleen [31].